Free Trial

Cresco Labs (OTCMKTS:CRLBF) Announces Quarterly Earnings Results

Cresco Labs logo with Medical background

Key Points

  • Cresco Labs reported earnings of ($0.05) per share, missing analysts' estimates of ($0.04) by ($0.01).
  • The company's revenue for the quarter was $163.62 million, slightly exceeding consensus estimates of $162 million.
  • Analysts have recently dropped the rating for Cresco Labs from "strong-buy" to "moderate buy," although it retains a consensus rating of "Buy."
  • Looking to Export and Analyze Cresco Labs Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) posted its earnings results on Thursday. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.01), Zacks reports. Cresco Labs had a negative net margin of 6.67% and a negative return on equity of 11.65%. The business had revenue of $163.62 million for the quarter, compared to analyst estimates of $162.00 million.

Cresco Labs Stock Performance

Shares of OTCMKTS:CRLBF traded up $0.07 during trading on Friday, reaching $0.75. 1,274,434 shares of the company's stock traded hands, compared to its average volume of 942,176. Cresco Labs has a 12 month low of $0.43 and a 12 month high of $2.05. The company has a debt-to-equity ratio of 1.63, a current ratio of 2.75 and a quick ratio of 1.98. The stock has a market capitalization of $366.59 million, a P/E ratio of -5.74 and a beta of 1.42. The company has a 50 day moving average of $0.57 and a 200-day moving average of $0.70.

Analyst Ratings Changes

Separately, Canaccord Genuity Group lowered shares of Cresco Labs from a "strong-buy" rating to a "moderate buy" rating in a report on Tuesday, June 3rd. Two investment analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy".

View Our Latest Stock Report on CRLBF

About Cresco Labs

(Get Free Report)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Read More

Earnings History for Cresco Labs (OTCMKTS:CRLBF)

Should You Invest $1,000 in Cresco Labs Right Now?

Before you consider Cresco Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.

While Cresco Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines